Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Polycystic Ovary Syndrome 3Peripheral Nervous System Diseases 3Ovarian Neoplasms 3Carcinoma, Hepatocellular 3Stomatitis 2Stomach Neoplasms 2Ototoxicity 2Neurofibromatosis 1 2Liver Neoplasms 2Hearing Loss 2Head and Neck Neoplasms 2Weight Loss 1Ulcer 1Tongue Neoplasms 1Tomaculous neuropathy 1Thrombocythemia, Essential 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Radiation-Induced Mucositis 1Radiation Pneumonitis 1Pseudomyxoma Peritonei 1Primary Myelofibrosis 1Primary Graft Dysfunction 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Polycythemia Vera 1Osteosarcoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroma 1

Interventions

AZD 6244 9Lovastatin 5Deoxycholic Acid 4trametinib 3Lasers, Solid-State 3mirdametinib 2fludarabine 2Transcranial Direct Current Stimulation 2Sirolimus 2Polidocanol 2Magnetic Resonance Imaging 2Lasers 2Lamotrigine 2Inhalation 2Acetylcysteine 2thymoglobulin 1talimogene laherparepvec 1peginterferon alfa-2b 1gadolinium compound P760 1fludarabine phosphate 1diphenylcyclopropenone 1cabozantinib 1binimetinib 1X-Rays 1Vitamin D 1Vincristine 1Vinblastine 1Temozolomide 1Surgical Procedures, Operative 1Sunitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Neurofibromatosis 1 × Acetylcysteine × Clear all
NCT04481048 2026-06-05

DoDNAC

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed
25 enrolled 12 charts
CNS

Attention Deficit Disorder with Hyperactivity, Neurofibromatosis 1

NCT04481035 2026-04-21

NF1NAC

Children's Hospital Medical Center, Cincinnati

Phase 2 Completed
5 enrolled 10 charts
CNS

Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡